Pfizer India Managing Director Kewal Handa On Drug Pricing, Patents And Access: An Interview With PharmAsia News (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
In one of his final interviews before retirement, long-time Pfizer Managing Director Kewal Handa discusses the Indian government’s policies on drug pricing, compulsory licensing and patents, and foreign direct investment.